Microbiology

  1. Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2

    1. Hirofumi Ohashi
    2. Takayuki Hishiki
    3. Daisuke Akazawa
    4. Kwang Su Kim
    5. Joohyeon Woo
    6. Kaho Shionoya
    7. Kana Tsuchimoto
    8. Shoya Iwanami
    9. Saya Moriyama
    10. Hitomi Kinoshita
    11. Souichi Yamada
    12. Yudai Kuroda
    13. Tsukasa Yamamoto
    14. Noriko Kishida
    15. Shinji Watanabe
    16. Hideki Hasegawa
    17. Hideki Ebihara
    18. Tadaki Suzuki
    19. Ken Maeda
    20. Shuetsu Fukushi
    21. Yoshimasa Takahashi
    22. Shingo Iwami
    23. Koichi Watashi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Mitoquinone mesylate targets SARS-CoV-2 infection in preclinical models

    1. Anton Petcherski
    2. Madhav Sharma
    3. Sandro Satta
    4. Maria Daskou
    5. Hariclea Vasilopoulos
    6. Cristelle Hugo
    7. Eleni Ritou
    8. Barbara Jane Dillon
    9. Eileen Fung
    10. Gustavo Garcia
    11. Claudio Scafoglio
    12. Arunima Purkayastha
    13. Brigitte N Gomperts
    14. Gregory A Fishbein
    15. Vaithilingaraja Arumugaswami
    16. Marc Liesa
    17. Orian S Shirihai
    18. Theodoros Kelesidis

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Omicron BA.1 and BA.2 are antigenically distinct SARS-CoV-2 variants

    1. Anna Z. Mykytyn
    2. Melanie Rissmann
    3. Adinda Kok
    4. Miruna E. Rosu
    5. Debby Schipper
    6. Tim I. Breugem
    7. Petra B. van den Doel
    8. Felicity Chandler
    9. Theo Bestebroer
    10. Maurice de Wit
    11. Martin E. van Royen
    12. Richard Molenkamp
    13. Bas B. Oude Munnink
    14. Rory D. de Vries
    15. Corine GeurtsvanKessel
    16. Derek J. Smith
    17. Marion P. G. Koopmans
    18. Barry Rockx
    19. Mart M. Lamers
    20. Ron Fouchier
    21. Bart L. Haagmans

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Bacterial metatranscriptomes in wastewater can differentiate virally infected human populations

    1. Rodolfo A Salido
    2. Cameron Martino
    3. Smruthi Karthikeyan
    4. Shi Huang
    5. Gibraan Rahman
    6. Antonio Gonzalez
    7. Livia S. Zaramela
    8. Kristen L Beck
    9. Shrikant Bhute
    10. Kalen Cantrell
    11. Anna Paola Carrieri
    12. Sawyer Farmer
    13. Niina Haiminen
    14. Greg Humphrey
    15. Ho-Cheol Kim
    16. Laxmi Parida
    17. Alex Richter
    18. Yoshiki Vázquez-Baeza
    19. Karsten Zengler
    20. Austin D. Swafford
    21. Andrew Bartko
    22. Rob Knight

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Potent Neutralizing Activity of Polyclonal Equine Antibodies against Omicron SARS-CoV-2

    1. J. Luczkowiak
    2. P. Radreau
    3. L. Nguyen
    4. N. Labiod
    5. F. Lasala
    6. C.H. Herbreteau
    7. R. Delgado

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model

    1. Caroline S. Foo
    2. Rana Abdelnabi
    3. Laura Vangeel
    4. Steven De Jonghe
    5. Dirk Jochmans
    6. Birgit Weynand
    7. Johan Neyts

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model

    1. Kyle Rosenke
    2. Atsushi Okumura
    3. Matthew C. Lewis
    4. Friederike Feldmann
    5. Kimberly Meade-White
    6. W. Forrest Bohler
    7. Amanda Griffin
    8. Rebecca Rosenke
    9. Carl Shaia
    10. Michael A. Jarvis
    11. Heinz Feldmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Characterization of various remdesivir-resistant mutations of SARS-CoV-2 by mathematical modeling and molecular dynamics simulation

    1. Shiho Torii
    2. Kwang Su Kim
    3. Jun Koseki
    4. Rigel Suzuki
    5. Shoya Iwanami
    6. Yasuhisa Fujita
    7. Yong Dam Jeong
    8. Yoshiharu Matsuura
    9. Teppei Shimamura
    10. Shingo Iwami
    11. Takasuke Fukuhara

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Serological screening in wild ruminants in Germany, 2021/2022: No evidence of SARS‐CoV‐2, bluetongue virus or pestivirus spread but high seroprevalences against Schmallenberg virus

    1. Kerstin Wernike
    2. Luisa Fischer
    3. Mark Holsteg
    4. Andrea Aebischer
    5. Anja Petrov
    6. Katharina Marquart
    7. Ulrich Schotte
    8. Jacob Schön
    9. Donata Hoffmann
    10. Silke Hechinger
    11. Antonie Neubauer‐Juric
    12. Julia Blicke
    13. Thomas C. Mettenleiter
    14. Martin Beer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model

    1. Drishya Kurup
    2. Christoph Wirblich
    3. Leila Zabihi Diba
    4. Rachael Lambert
    5. Megan Watson
    6. Noor Shaikh
    7. Holly Ramage
    8. Charalambos Solomides
    9. Matthias J. Schnell

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 109 of 251 Next